Spatial transcriptomic analysis of the ImmunoADAPT trial: Neoadjuvant endocrine therapy combined with palbociclib and avelumab in early-stage ER-positive breast cancer. This is an ASCO Meeting ...
The worldwide impact of HER2-targeted treatments in women with breast cancer: An epidemiological modeling study. Validation of a novel and rapid reagent free assay to predict outcomes for adjuvant ...
—Building on earlier findings, researchers sought to determine rates of neoadjuvant systemic therapy (NST) among U.S. women with cT1–2 N0 M0 HER2-positive breast cancer, plus identify factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results